Viragen Inc (VRAI)
Introduction
With international operations in the U.S., Scotland and Sweden, we are a bio-pharmaceutical company engaged in the research, development, manufacture and commercialization of therapeutic proteins for the treatment of cancers and viral diseases. Our product and product candidate portfolio includes: Multiferon ® (multi-subtype, human alpha interferon) uniquely positioned in valuable niche indications, such as high-risk malignant melanoma, other niche cancer indications and selected infectious diseases; VG101 (anti-GD3 antibody), a humanized monoclonal antibody that binds selectively to an antigen over-expressed on Stage IV...
read more
With international operations in the U.S., Scotland and Sweden, we are a bio-pharmaceutical company engaged in the research, development, manufacture and commercialization of therapeutic proteins for the treatment of cancers and viral diseases. Our product and product candidate portfolio includes: Multiferon ® (multi-subtype, human alpha interferon) uniquely positioned in valuable niche indications, such as high-risk malignant melanoma, other niche cancer indications and selected infectious diseases; VG101 (anti-GD3 antibody), a humanized monoclonal antibody that binds selectively to an antigen over-expressed on Stage IV...
Contact Information:
| Business Address: | 865 SW 78TH AVENUE SUITE 100 PLANTATION FL 33324 9542338746 |
| Mailing Address: | 865 SW 78TH AVENUE SUITE 100 PLANTATION FL 33324 |
| Phone: | 954-233-8746 |
| Fax: | 954-233-1414 |
| Website: | http://www.viragen.com |
Company Details:
| Symbol: | VRAI |
| SIC: | - |
| State location: | FL |
| Sector: | - |
| State of Inc: | DE |
| Employees: | 54 |
| Type: | PINK-SHEET |
Key executives:
| Name | Age | Position |
|---|---|---|
| Carl N. Singer | 94 | Chairman, Chairman of Exec. Committee, Chairman of the board of Viragen International Inc., Chief Exec. Officer of Viragen International Inc. and Pres of Viragen International Inc |
| Charles A. Rice | 61 | Chief Exec. Officer, Pres, Director, Chief Exec. officer of Viragen International Inc, Pres of Viragen International Inc of Viragen International Inc |
| Dennis W. Healey | 64 | Chief Financial Officer, Exec. VP, Sec., Treasurer, Exec. VP of Viragen International Inc, Sec. of Viragen International Inc and Treasurer of Viragen International Inc |
| Douglas Calder | - | Director of Communications |
| Robert C. Salisbury | 68 | Director, Chairman of Nominating & Governance Committee, Member of Compensation Committee, Member of Audit & Fin. CommitteeChief Exec. Officer of ViraGenics Inc. and Pres of ViraGenics Inc |
| Post # | Subject | Re | Name | Date |
|---|---|---|---|---|
| There are no comments. | ||||


someone replies to your post?